According to Amarin Corporation 's latest financial reports and stock price the company's current Operating Margin is -24.94%. At the end of 2021 the company had an Operating Margin of 1.94%.
Year | Operating Margin | Change |
---|---|---|
2021 | 1.94% | -168.9% |
2020 | -2.81% | -46.28% |
2019 | -5.23% | -89.69% |
2018 | -50.76% | 67.7% |
2017 | -30.27% | -48.45% |
2016 | -58.72% | -59.42% |
2015 | -144.69% | 32.47% |
2014 | -109.22% | -83.01% |
2013 | -642.94% | |
2006 | -5,543.80% | 42.84% |
2005 | -3,881.00% | -447.9% |
2004 | 1,115.54% | -409.1% |
2003 | -360.90% | 604.75% |
2002 | -51.21% | 484.39% |
2001 | -8.76% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
AbbVie ABBV | 18.65% | -174.78% | ๐บ๐ธ USA |
AstraZeneca AZN | 5.63% | -122.57% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | 22.54% | -190.38% | ๐ฌ๐ง UK |
Alkermes ALKS | -15.04% | -39.70% | ๐ฎ๐ช Ireland |
Teva Pharmaceutical Industries TEVA | -20.53% | -17.68% | ๐ฎ๐ฑ Israel |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.